tiprankstipranks
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market
Holding PRAX?
Track your performance easily

Praxis Precision Medicines (PRAX) Ownership - Who Owns Praxis Precision Medicines?

553 Followers

Praxis Precision Medicines (PRAX) Ownership Overview

10.51%13.70%48.89%13.14%13.76%
10.51% Insiders
48.89% Other Institutional Investors
13.14% ETFs
13.76% Public Companies and Individual Investors
The ownership structure of Praxis Precision Medicines (PRAX) stock is a mix of institutional, retail, and individual investors. Approximately 75.73% of the company’s stock is owned by Institutional Investors, 10.51% is owned by Insiders, and 13.76% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 15, 2024
xxxxxxxxxxxxx
$424275
Nov 15, 2024
Alex Nemiroff
Gc & Secretary
xxxxxxxxxxxxx
$660768

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$9554862
Sep 30, 2024
xxxxxxxxxxxxx
$18591461
Sep 30, 2024
xxxxxxxxxxxxx
$43842890
Sep 30, 2024
xxxxxxxxxxxxx
$66978573

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,789,226Insider9.60%130,720,852
1,164,035Institution6.25%85,044,397
992,237Institution5.32%72,492,835
773,650Institution4.15%56,522,869
761,955Institution4.09%55,668,432
700,693Institution3.76%51,192,631
405,197Institution2.17%29,603,693
323,105Institution1.73%23,606,051
290,810Institution1.56%21,246,579
264,511Institution1.42%19,325,174

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
773,650Institution4.15%56,522,869
290,810Institution1.56%21,246,579
264,511Institution1.42%19,325,174
240,409Institution1.29%17,564,282
183,818Institution0.99%13,429,743
183,651Institution0.99%13,417,542
147,815Institution0.79%10,799,364
138,504Institution0.74%10,119,102
87,676Institution0.47%6,405,609
54,253Institution0.29%3,963,724

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
562,188Institution3.02%39,347,538
467,834Institution2.51%34,179,952
375,642Institution2.02%27,677,303
252,116Institution1.35%17,645,599
154,478Institution0.83%11,286,163
80,468Institution0.43%5,928,882
75,970Institution0.41%5,550,368
78,613Institution0.42%5,502,124
47,565Institution0.26%3,475,099
42,671Institution0.23%2,986,543

FAQ

Who Owns Praxis Precision Medicines (PRAX)?
According to the latest TipRanks data, approximately 48.89% of the company's stock is held by institutional investors, 10.51% is held by insiders, and 13.76% is held by retail investors.
    What percentage of Praxis Precision Medicines (PRAX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.89% of Praxis Precision Medicines (PRAX) stock is held by institutional investors.
      What percentage of Praxis Precision Medicines (PRAX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.76% of Praxis Precision Medicines (PRAX) stock is held by retail investors.
        Who owns the most shares of Praxis Precision Medicines (PRAX)?
        Steven A. Cohen owns the most shares of Praxis Precision Medicines (PRAX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis